Canada Pension Plan Investment Board’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
Canada Pension Plan Investment Board's MRNA Position: Q2 2026 in Review
Canada Pension Plan Investment Board reduced its Moderna (MRNA) stake by 23% in Q2 2026, selling an estimated $3.22M and leaving 213,808 shares worth $15M. The position accounts for 0.01% of the portfolio, ranked #599.
Canada Pension Plan Investment Board first reported a position in MRNA in Q4 2018 and has held it in 31 quarters since. The position peaked at $413M in Q3 2021. 780 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.
- Canada Pension Plan Investment Board held 213,808 shares of Moderna worth $15M as of Q2 2026.
- Canada Pension Plan Investment Board sold 62,261 Moderna shares in Q2 2026, an estimated $3.22M.
- Moderna made up 0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #599 holding.
- Canada Pension Plan Investment Board first reported a position in Moderna in Q4 2018 and has held it in 31 quarters since.
- Canada Pension Plan Investment Board's Moderna position peaked at $413M in Q3 2021.
- 780 funds tracked by Wall St. Rank held Moderna as of Q2 2026.
Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.